164 related articles for article (PubMed ID: 30878131)
1. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
3. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
4. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia].
Yuan DM; Wu SY; Huang SL; Jiang WC; Ke YB
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1252-1258. PubMed ID: 28910942
[No Abstract] [Full Text] [Related]
5. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
8. Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases.
Shafik RE; Abd El Wahab N; Senoun SA; Ebeid E; El Taweel MA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2263-2267. PubMed ID: 30139235
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
Rashed WM; Hamza MM; Matboli M; Salem SI
Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of circulating miR-22, miR-122, miR-217 and miR-367 as promising biomarkers of acute lymphoblastic leukemia.
Hosseinpour-Soleimani F; Khamisipour G; Derakhshan Z; Ahmadi B
Mol Biol Rep; 2023 Jan; 50(1):255-265. PubMed ID: 36327023
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.
Swellam M; El-Khazragy N
Tumour Biol; 2016 Aug; 37(8):10571-6. PubMed ID: 26857279
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
15. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
17. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
18. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
19. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
20. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]